Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $41.07 million. The enterprise value is -$47.26 million.

Market Cap	41.07M
Enterprise Value	-47.26M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 41.49 million shares outstanding. The number of shares has increased by 12.99% in one year.

Current Share Class	41.49M
Shares Outstanding	41.49M
Shares Change (YoY)	+12.99%
Shares Change (QoQ)	+8.23%
Owned by Insiders (%)	5.58%
Owned by Institutions (%)	27.45%
Float	18.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	137.48
Forward PS	n/a
PB Ratio	0.51
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.52, with a Debt / Equity ratio of 0.00.

Current Ratio	7.52
Quick Ratio	7.29
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.39% and return on invested capital (ROIC) is -42.04%.

Return on Equity (ROE)	-67.39%
Return on Assets (ROA)	-38.54%
Return on Capital (ROIC)	-42.04%
Revenue Per Employee	$6,953
Profits Per Employee	-$1.72M
Employee Count	43
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.77% in the last 52 weeks. The beta is -1.67, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-1.67
52-Week Price Change	-71.77%
50-Day Moving Average	1.09
200-Day Moving Average	1.45
Relative Strength Index (RSI)	37.48
Average Volume (20 Days)	90,994

Short Selling Information

The latest short interest is 536,633, so 1.29% of the outstanding shares have been sold short.

Short Interest	536,633
Short Previous Month	582,331
Short % of Shares Out	1.29%
Short % of Float	2.83%
Short Ratio (days to cover)	10.09

Income Statement

In the last 12 months, Rallybio had revenue of $299,000 and -$73.88 million in losses. Loss per share was -$1.78.

Revenue	299,000
Gross Profit	749,000
Operating Income	-74.00M
Pretax Income	-73.88M
Net Income	-73.88M
EBITDA	-73.86M
EBIT	-74.00M
Loss Per Share	-$1.78

Full Income Statement

Balance Sheet

The company has $88.61 million in cash and $284,000 in debt, giving a net cash position of $88.33 million or $2.13 per share.

Cash & Cash Equivalents	88.61M
Total Debt	284,000
Net Cash	88.33M
Net Cash Per Share	$2.13
Equity (Book Value)	80.02M
Book Value Per Share	1.93
Working Capital	79.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.99 million and capital expenditures -$12,000, giving a free cash flow of -$54.00 million.

Operating Cash Flow	-53.99M
Capital Expenditures	-12,000
Free Cash Flow	-54.00M
FCF Per Share	-$1.30

Full Cash Flow Statement

Margins

Gross Margin	250.50%
Operating Margin	-24,748.16%
Pretax Margin	-24,709.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-18,061.20%

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.99%
Shareholder Yield	-12.99%
Earnings Yield	-179.88%
FCF Yield	-131.48%

Analyst Forecast

The average price target for Rallybio is $8.30, which is 738.38% higher than the current price. The consensus rating is "Buy".

Price Target	$8.30
Price Target Difference	738.38%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rallybio has an Altman Z-Score of -0.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.19
Piotroski F-Score	1